NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Nicholas I Simon
National Institutes of Health - Bethesda, Maryland / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4388329
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Nicholas I Simon's MOST POPULAR ARTICLES
1-)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 InhibitorsProstate …C Cai, S Chen, P Ng, GJ Bubley, PS Nelson, EA Mostaghel, B Marck, ...Cancer research 71 (20), 6503-6513, 20114502011
2-)
Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non‐small cell lung cancerYK Chae, AA Davis, S Agte, A Pan, NI Simon, WT Iams, MR Cruz, ...The oncologist 24 (6), 820-828, 20191022019
3-)
Galeterone prevents androgen receptor binding to chromatin and enhances degradation of mutant androgen receptorZ Yu, C Cai, S Gao, NI Simon, HC Shen, SP BalkClinical Cancer Research 20 (15), 4075-4085, 20141012014
4-)
Discovery of a selective irreversible BMX inhibitor for prostate cancerF Liu, X Zhang, E Weisberg, S Chen, W Hur, H Wu, Z Zhao, W Wang, ...ACS Chemical Biology 8 (7), 1423-1428, 2013542013
5-)
Best approaches and updates for prostate cancer biochemical recurrenceNI Simon, C Parker, TA Hope, CJ PallerAmerican Society of Clinical Oncology Educational Book 42, 352-359, 2022322022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept